Investigation of Long-term Survivors with Stage IV Gastric Cancer.
10.5230/jkgca.2002.2.3.157
- Author:
Sung Joon KWON
1
Author Information
1. Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea. sjkwon@hanyang.ac.kr
- Publication Type:Original Article
- Keywords:
Stage IV gastric cancer;
Long-term survivor;
Prognostic factor
- MeSH:
Drug Therapy;
Gastrectomy;
Hand;
Humans;
Lymph Nodes;
Neoplasm Metastasis;
Prognosis;
Stomach Neoplasms*;
Survivors*
- From:Journal of the Korean Gastric Cancer Association
2002;2(3):157-162
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The prognosis of stage IV gastric cancer is very grave. However, some of these patients survive long periods after surgery. This study was undertaken to investigate various clinico-pathological profiles related to the prognosis for these long-term survivors. MATENRIALS AND METHODS: One hundred fifty-five patients with stage IV gastric cancer who underwent a gastric resection from 1992 to 1997 at Hanyang University Hospital were evaluated. Thirty-three patients who survived more than 5 years after surgery were designated as long-term survivors (LTS); on the other hand, one hundred twenty-two patients who died within 5 years after surgery were named as short-term survivors (STS). RESULTS: The rate of the patients with T4, preoperative serum level of CA19-9 greater than 37 U/g protein, and peritoneal dissemination was lower for the LTS than in for the STS (P=0.002, P=0.045, and P=0.0000, respectively). Tumors were smaller (7.3 cm vs. 8.9 cm, P=0.030) and metastatic lymph node were fewer (19.7 vs. 28.8, P=0.019) for the LTS than for the STS. Curative surgery (76% vs. 46%, P=0.002) and a subtotal gastrectomy (64% vs. 42%, P=0.026) were performed more frequently for the LTS than for the STS. From a univariate survival analysis, depth of invasion, distant metastasis, extent of gastric resection, postoperative chemotherapy, and curability were statistically significant factors. From a multivariate survival analysis, curability, depth of invasion, and extent of gastric resection were independent prognostic factors. CONCLUSION: If feasible, we have to exert our efforts to achieve curative surgery although the tumor is considered to be a stage IV gastric cancer. Thereafter, multi-modality treatments including chemotherapy can be considered to improve the prognosis.
